Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC5A2 | P31639 | 16/20 | 0.67 |
| ▸ | SLC5A1 | P13866 | 12/20 | 0.67 |
| ▸ | TYMP | P19971 | 1/20 | 0.40 |
| ▸ | ACHE | P22303 | 1/20 | 0.39 |
| ▸ | SLC28A3 | Q9HAS3 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14181361 | 0.92 | SLC5A2 (0.77) | SLC5A2SLC5A1TYMP | |
| SCHEMBL4361439 | 0.89 | SLC5A2 (0.75) | SLC5A2SLC5A1TYMPACHESLC28A3 | |
| SCHEMBL5343994 | 0.89 | SLC5A2 (0.75) | SLC5A2SLC5A1TYMP | |
| SCHEMBL4367084 | 0.89 | SLC5A2 (0.75) | SLC5A2SLC5A1TYMP | |
| SCHEMBL4361433 | 0.89 | SLC5A2 (0.75) | SLC5A2SLC5A1TYMPACHESLC28A3 | |
| SCHEMBL4360297 | 0.88 | SLC5A2 (0.86) | SLC5A2SLC5A1ACHE | |
| SCHEMBL6385411 | 0.88 | SLC5A2 (0.70) | SLC5A2SLC5A1TYMPACHESLC28A3 | |
| SCHEMBL4360304 | 0.88 | SLC5A2 (0.86) | SLC5A2SLC5A1ACHE | |
| SCHEMBL6385418 | 0.88 | SLC5A2 (0.70) | SLC5A2SLC5A1TYMPACHESLC28A3 | |
| SCHEMBL4823219 | 0.84 | SLC5A2 (0.73) | SLC5A2SLC5A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7371732-B2 | Glucopyranosyloxy-substituted aromatic compounds, medicaments containing such compounds, their use and process for their manufacture | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2008-05-13 | — | — | US | disclosed |
| US-7371732-B2 | Glucopyranosyloxy-substituted aromatic compounds, medicaments containing such compounds, their use and process for their manufacture | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2008-05-13 | — | — | US | disclosed |
| US-7371732-B2 | Glucopyranosyloxy-substituted aromatic compounds, medicaments containing such compounds, their use and process for their manufacture | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2008-05-13 | — | — | US | disclosed |
| US-20050187168-A1 | Glucopyranosyloxy-substituted aromatic compounds, medicaments containing such compounds, their use and process for their manufacture | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2005-08-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050187168-A1 | Glucopyranosyloxy-substituted aromatic compounds, medicaments containing such compounds, their use and process for their manufacture | SLC5A2, SLC5A1, SLC2A4 | SLC5A2 1/4885SLC5A1 2/4885TYMP 1666/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.